The Medicinal Bioconvergence Research Center of Seoul National University (or Biocon) has set a challenge to establish an “innovative research platform for drug discovery” that can significantly reduce the time and cost while improving the success probability of drug discovery.
Among the many different stages required for drug development, Biocon focuses on the “identification and validation of novel drug targets”. Although well-validated druggable targets are critical determinants for the success of drug discovery, target discovery is typically a function that pharma or biotech industry launch in-house, because it involves much basic science and there are no standard operation procedures for this process. Therefore, druggable targets have to be provided by the researchers in academia and public sectors. Biocon was established to fill the gap between academia and industry by maturing potentially druggable targets.
The identification of novel targets involves a broad spectrum of research activity from in-depth basic biology to translation. The strength of Biocon is based on the integration of biology and chemistry teams combined with cutting-edge convergence technologies. Through this fully united research teamwork, Biocon is aiming to become the world’s first and best target factory, providing innovative targets to the pharmaceutical industry.
We are a fairly small, flexible design studio that designs for print and web. We work flexibly with clients to fulfill their design needs. Whether you need to create a brand completely from scratch or are looking for a design refresh, we are confident that you and your team will be satisfied with the results.
Suwon Office (Main)
- Address : B-8, Advanced Institutes of Convergence Technology, 145, Gwanggyo-ro, Yeongtong-gu, Suwon-si, Gyeonggi-do, 16229, Korea
경기도 수원시 영통구 광교로 145 차세대융합기술원 B동 8층
- Tel : +82-31-888-9292
- Fax : +82-31-888-9294
- Address : Bldg. 29 Rm 213, Seoul National University, 1, Gwanak-ro, Gwanak-gu, Seoul, 08826, Korea
서울특별시 관악구 관악로 1 서울대학교 약학대학 29동 213호
- Tel : +82-2-880-8180